BioXcel Therapeutics (BTAI) EPS (Diluted) (2020 - 2026)
BioXcel Therapeutics (BTAI) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 7.27 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.39 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.24 Mn | 24.24 Mn | 160,000.00 | -0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.47 |
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | -1.26 |
| Jun 30, 2025 | -2.53 |
| Mar 31, 2025 | -2.86 |
| Dec 31, 2024 | -2.86 |
| Sep 30, 2024 | -6.97 |
| Jun 30, 2024 | -8.08 |
| Mar 31, 2024 | -13.90 |
| Dec 31, 2023 | -11.53 |
| Sep 30, 2023 | -29.82 |
| Jun 30, 2023 | -32.90 |
| Mar 31, 2023 | -47,680.65 |
| Dec 31, 2022 | -96.97 |
| Sep 30, 2022 | -33.42 |
| Jun 30, 2022 | -34.16 |
| Mar 31, 2022 | -44.69 |
| Dec 31, 2021 | -15.85 |
| Sep 30, 2021 | -53.42 |